297
report
Turning Plants Into Products: Delivering on the Potential of Industrial Biotechnology
As interest in sustainability grows in the United States and around the world, there is a push by p
olicymakers and the industrial biotechnology industry to find replacements for petroleum.
+ Read More
report
Unleashing the Power of the Bio-Economy
In April 2012, the Milken Institute, with support from the U.S. Department of Agriculture, hosted a
Financial Innovations Lab on ideas to spur the industrial side of bio-based alternatives to petrochemicals.
+ Read More
report
Understanding and Identifying Gaps in Employer Mental Health Resources
About 60 million Americans live with mental health conditions, and nearly half of those go without
treatment. The COVID-19 pandemic widened the gap between employers and employees on mental health in the workplace.
+ Read More
report
A Global Early Warning System for Pandemics: Perspectives from the Front Lines
The COVID-19 pandemic exposed critical gaps in the world’s ability to detect, track, and analyze pa
ndemic threats.
+ Read More
report
Projected Prevalence and Cost of Dementia: 2022 Update
The 2022 update on Alzheimer's Disease and Related Dementias (ADRD) highlights that:
report
Financial Innovations Lab: Integrating ESG Data to Improve Risk Management and Municipal Resilience
Sustainable debt investments and the market for ESG data continue to expand. But without effective
measuring and tracking of the ESG risks specific to each community, there is a limit to that growth. What’s unmeasured can’t be managed.
+ Read More
report
Policy Brief: Improving Women, Infants, and Children’s Access to Food and Care During the COVID-19 Pandemic
To address the impact that the COVID-19 virus is having on food access, this issue brief highlights
recent policies and puts forward a recommendation to ensure that the over 6 million individuals who participate in the Special Supplemental Nutrition Pro
+ Read More
report
Demographic Reporting and Mix in Clinical Trials
Clinical trial enrollment can vary based on demographics. Cancer drug trials, for example, have bee
n shown to skew disproportionately toward young, White, male participants.
+ Read More
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Clinical Developments in Follicular Lymphoma
Follicular lymphoma (FL) is a rare, slow-growing cancer that affects certain blood cells. People ex
periencing this form of non-Hodgkin lymphoma face multiple relapses over the course of their disease, which can run for years and sometimes decades.
+ Read More
report
Childhood Brain Cancer: A Giving Smarter Guide
Pediatric brain cancer accounts for 16 percent of all new childhood cancer diagnoses, making it one
of the most common cancer diagnoses in children and adolescents. It is also the leading cause of cancer death within this age group.
+ Read More
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More